Kiniksa Pharmaceuticals Ltd. (KNSA) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

Kiniksa Pharmaceuticals L...

NASDAQ: KNSA · Real-Time Price · USD
36.49
0.98 (2.76%)
At close: Sep 26, 2025, 3:59 PM
36.02
-1.29%
After-hours: Sep 26, 2025, 06:45 PM EDT

Kiniksa Pharmaceuticals Revenue

Kiniksa Pharmaceuticals reported an annual revenue of $423.24M, reflecting a 56.6% growth. For the quarter ending June 30, 2025, Kiniksa Pharmaceuticals generated $156.8M in revenue.
Revenue (ttm)
423.24M
Revenue Growth
56.6%
Price / Sales Ratio
3.34
Revenue / Employee
1.34M
Employees
315
Market Cap
2.7B

Revenue Chart

History

Fiscal Year End Revenue % Change
Dec 31, 2024 423.24M +56.60%
Dec 31, 2023 270.26M +22.74%
Dec 31, 2022 220.18M +471.24%
Dec 31, 2021 38.54M +Infinity%
Dec 31, 2020 0 n/a
Dec 31, 2019 0 n/a
Dec 31, 2018 0 n/a
Dec 31, 2017 0 n/a
Dec 31, 2016 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.